Subsequent Survival and Loss of Lifetime for Patients With Progression‐Free 24 Months After Treatment in Nasopharyngeal Carcinoma: A Comprehensive Nationwide Population‐Based Analysis

Subsequent Survival and Loss of Lifetime for Patients With Progression‐Free 24 Months After Treatment in Nasopharyngeal Carcinoma: A Comprehensive Nationwide Population‐Based Analysis

ABSTRACT Currently, there is little evidence supporting the use of early endpoints to assess primary treatment outcomes in nasopharyngeal carcinoma (NPC). We aim to explore the relationship between 24‐month progression‐free survival (PFS24) and subsequent overall survival (sOS) as well as loss of li...

Full description

Saved in:
Bibliographic Details
Main Authors: Yang Liu, Yaqian Han, Mei Feng, Ye Zhang, Kai Wang, Yuan Qu, Xuesong Chen, Jianghu Zhang, Jingwei Luo, Runye Wu, Ye‐Xiong Li, Xiaodong Huang, Qiuyan Chen, Jingbo Wang, Junlin Yi
Format: Article
Language:English
Published: Wiley 2025-04-01
Series:MedComm
Subjects:
early recurrence
loss of lifetime
nasopharyngeal carcinoma
standardized mortality ratio
subsequent survival
surrogate endpoint
Online Access:https://doi.org/10.1002/mco2.70143
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items